[ Price : $8.95]
A Texas federal judge rules FDA acted properly in removing Novo Nordisks Ozempic and Wegovy from its drug shortage list.[ Price : $8.95]
Former FDA commissioner Scott Gottlieb expects FDA will reevaluate Sareptas approval of Duchenne muscular dystrophy gene therapy E...[ Price : $8.95]
FDA Webview closes and will not be publishing on 6/19 in recognition of the U.S. federal holiday, Juneteenth.[ Price : $8.95]
FDA warns Irving, TX-based Reset Technology Corp. about Quality System and other violations in its production of two dental device...[ Price : $8.95]
Sarepta Therapeutics halts shipments of its gene therapy Elevidys (delandistrogene moxeparvovec‑rokl) to nonR...[ Price : $8.95]
FDA warns Indias Kenil Private Healthcare about CGMP violations in its production of finished drugs.[ Price : $8.95]
FDA approves updated labeling on Pfizers s Talzenna (talazoparib) in combination with Xtandi (enzalutamide) for men with metastati...[ Price : $8.95]
FDA launches the Commissioners National Priority Vouchers to speed drug reviews for companies with products that are aligned with ...